Incyte
(NASDAQ:INCY)
$52.56
0.88[1.70%]
At close: Apr 29
$52.56
0[0.00%]
After Hours: 4:01PM EDT
Q1 2024 earnings tomorrow on Tue Apr 30th before the market open
Conference call scheduled tomorrow at 8:00 AM Click to view the webcast
Escient Pharmaceuticals announced it will be acquired by Incyte (INCY) on Tuesday, April 23, 2024 for $750.0M paid in cash

Incyte Stock (NASDAQ:INCY), Insider Trading Activity

Incyte: Insider buying and selling updated today.

Insider Shares Owned
3.939M
Insider Percentage Owned
1.75%
Institutional Shares Held
110.540M
Institutional Percentage Held
49.3%
Filing Date
▲▼
Insider Names
▲▼
Insider Title
▲▼
Qty.
▲▼
Price
▲▼
Size ($)
▲▼
Type
▲▼
Δ Own
▲▼
Own
▲▼
Trade Dates
▲▼
SEC Filing
▲▼
Jan 05, 2024Steven SteinEVP & CHIEF MEDICAL OFFICER-7.365K$65.51-$482.48KSELL-7.55%90.218KJan 03View
Jan 04, 2024Vijay IyengarEVP, GMAPPS-657$65.00-$42.70KSELL-1.49%43.412KJan 02View
Dec 14, 2023Thomas TrayPRINCIPAL ACCOUNTING OFFICER-1.277K$61.55-$78.59KSELL-5.17%23.436KDec 12 - Dec 13View
Sep 06, 2023PAULA SWAINEVP, HUMAN RESOURCES-8.449K$65.13-$550.28KSELL-9.83%77.53KSep 01View
Aug 03, 2023Steven SteinEVP & CHIEF MEDICAL OFFICER-21.511K$63.28-$1.36MSELL-18.06%97.583KAug 01View
Feb 02, 2023Maria PasqualeEVP & GENERAL COUNSEL0$79.42-$7.44KSELL-OPTIONS0.00%68.524KJan 31View
Feb 01, 2023Maria PasqualeEVP & GENERAL COUNSEL0$79.07-$681.35KSELL-OPTIONS0.00%68.524KJan 30View
Jan 30, 2023Vijay IyengarEVP, GMAPPS0$76.81-$114.66KSELL-OPTIONS0.00%42.835KJan 26View
Jan 30, 2023Dashyant DhanakEVP & CHIEF SCIENTIFIC OFFICER-2.419K$85.00-$205.62KSELL-4.34%53.263KJan 26View
Jan 06, 2023Steven SteinEVP & CHIEF MEDICAL OFFICER-28.399K$79.78-$2.27MSELL-20.67%109.021KJan 04View
Dec 28, 2022Vijay IyengarEVP, GMAPPS-2.458K$75.83-$346.28KSELL-6.10%37.855KDec 23View
Dec 21, 2022Thomas TrayPRINCIPAL ACCOUNTING OFFICER-1.223K$82.16-$100.48KSELL-6.86%16.606KDec 19View
Jul 26, 2022Thomas TrayPRINCIPAL ACCOUNTING OFFICER-1.564K$83.13-$130.02KSELL-8.12%17.702KJul 22View
Jul 11, 2022Vijay IyengarEVP, GMAPPS-5.787K$79.38-$459.37KSELL-12.55%40.313KJul 07View
Jul 11, 2022Barry FlannellyEVP & GENERAL MANAGER US-2.873K$79.38-$228.06KSELL-3.80%72.674KJul 07View
Apr 12, 2022Barry FlannellyEVP & GENERAL MANAGER US-2.129K$76.98-$722.26KSELL-3.16%65.163KApr 08View
Mar 10, 2022BAKER BROS ADVISORS LP LPJULIAN BAKERBaker Bros Advisors GP LLCBaker Brothers Life Sciences LPFELIX BAKERDIRECTOR429.08K$67.56$28.99MBUY1.30%33.452465MMar 08 - Mar 10View
Feb 22, 2022BAKER BROS ADVISORS LP LPJULIAN BAKERBaker Bros Advisors GP LLCBaker Brothers Life Sciences LPFELIX BAKERDIRECTOR525.804K$67.96$35.73MBUY1.62%33.073014MFeb 17 - Feb 22View
Feb 14, 2022BAKER BROS ADVISORS LP LPJULIAN BAKERBaker Bros Advisors GP LLCBaker Brothers Life Sciences LPFELIX BAKERDIRECTOR1.598374M$66.91$106.95MBUY4.73%35.405318MFeb 10 - Feb 14View

FAQ

Q

Is Insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch